News

Thiopurine drugs suppress the immune system and are used in the treatment of a wide range of diseases, such as inflammatory bowel disease, leukemia and lymphoma, autoimmune diseases

Mr Ehlers most recently served as the George Barth Geller professor in the department of neurobiology at Duke University and as an investigator with the Howard Hughes Medical

The facility, the second FlexFactory at the company’s headquarters site, will expand Xcellerex’s capacity to provide bridge biomanufacturing services for clients that are planning or building their own

Sysmex America was also awarded a three-year sole-source hematology agreement for Premier’s Accelerated Supply Chain Endeavor (ASCEND) program member-participants. ASCEND helps Premier members achieve sustained improvement in supply

The compounds are functionally liver-selective Glucokinase Activators (GKAs), which represent a novel class of glucose-lowering agents for the treatment of diabetes. Through the license agreement, Forest is expected

Astellas has completed the acquisition of OSI through a short-form merger without a meeting of OSI’s stockholders. In the merger, each outstanding share of OSI common stock not

Discovery Labs claimed that if approved, Surfaxin would be the first synthetic, peptide-containing surfactant for commercial use in neonatal medicine. Discovery Labs plans to submit its complete response

Almac IXRS 2.0 smart menu technology presents users with valid options and guides them to correct choices, directing their workflow in a logical and intuitive manner. According to

Novacta Biosystems, a UK-based biotechnology company controlled by Celtic Pharma, is focused on bringing new and modern anti infective therapies to the market. DSM it has completed the